Surviving Covid-19 with Heparin?

Ten Cate, Hugo

Ten Cate, Hugo.

Ten Cate H; From the Thrombosis Expertise Center, Department of Internal Medicine, Maastricht University Medical Center and Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands, and the Center for Thrombosis and Hemostasis, Gutenberg University Medical Center, Mainz, Germany.

N Engl J Med ; 385(9): 845-846, 2021 08 26.

Article in English | MEDLINE | ID: covidwho-1341032

Subject(s)

Anticoagulants/administration & dosage; COVID-19 Drug Treatment; Heparin, Low-Molecular-Weight/administration & dosage; Heparin/administration & dosage; Thrombosis/prevention & control; Anticoagulants/therapeutic use; Critical Illness; Dose-Response Relationship, Drug; Heparin/therapeutic use; Heparin, Low-Molecular-Weight/therapeutic use; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Heparin / Heparin, Low-Molecular-Weight / COVID-19 Drug Treatment / Anticoagulants Type of study: Prognostic study Limits: Humans Language: English Journal: N Engl J Med Year: 2021 Document Type: Article Affiliation country: NEJMe2111151

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google